Refine
Year of publication
Document Type
- Article (53)
- Preprint (15)
- Conference Proceeding (1)
- Review (1)
- Working Paper (1)
Has Fulltext
- yes (71)
Is part of the Bibliography
- no (71)
Keywords
- LHC (3)
- ALICE (2)
- Neuroscience (2)
- Shell model (2)
- 3Cs technology (1)
- 900 GeV (1)
- ADHD (1)
- Amygdala (1)
- Antifungal agents (1)
- Aspergillosis (1)
Institute
- Physik (41)
- Frankfurt Institute for Advanced Studies (FIAS) (26)
- Informatik (25)
- Medizin (17)
- ELEMENTS (5)
- Biowissenschaften (4)
- Geowissenschaften (4)
- Biochemie und Chemie (1)
- Extern (1)
- Exzellenzcluster Makromolekulare Komplexe (1)
- Gesellschaftswissenschaften (1)
- Neuere Philologien (1)
- Rechtswissenschaft (1)
Mitochondrial dynamics and mitophagy play a key role in ensuring mitochondrial quality control. Impairment thereof was proposed to be causative to neurodegenerative diseases, diabetes, and cancer. Accumulation of mitochondrial dysfunction was further linked to aging. Here we applied a probabilistic modeling approach integrating our current knowledge on mitochondrial biology allowing us to simulate mitochondrial function and quality control during aging in silico. We demonstrate that cycles of fusion and fission and mitophagy indeed are essential for ensuring a high average quality of mitochondria, even under conditions in which random molecular damage is present. Prompted by earlier observations that mitochondrial fission itself can cause a partial drop in mitochondrial membrane potential, we tested the consequences of mitochondrial dynamics being harmful on its own. Next to directly impairing mitochondrial function, pre-existing molecular damage may be propagated and enhanced across the mitochondrial population by content mixing. In this situation, such an infection-like phenomenon impairs mitochondrial quality control progressively. However, when imposing an age-dependent deceleration of cycles of fusion and fission, we observe a delay in the loss of average quality of mitochondria. This provides a rational why fusion and fission rates are reduced during aging and why loss of a mitochondrial fission factor can extend life span in fungi. We propose the ‘mitochondrial infectious damage adaptation’ (MIDA) model according to which a deceleration of fusion–fission cycles reflects a systemic adaptation increasing life span.
Introduction: Evidence from a number of open-label, uncontrolled studies has suggested that rituximab may benefit patients with autoimmune diseases who are refractory to standard-of-care. The objective of this study was to evaluate the safety and clinical outcomes of rituximab in several standard-of-care-refractory autoimmune diseases (within rheumatology, nephrology, dermatology and neurology) other than rheumatoid arthritis or non-Hodgkin's lymphoma in a real-life clinical setting.
Methods: Patients who received rituximab having shown an inadequate response to standard-of-care had their safety and clinical outcomes data retrospectively analysed as part of the German Registry of Autoimmune Diseases. The main outcome measures were safety and clinical response, as judged at the discretion of the investigators.
Results: A total of 370 patients (299 patient-years) with various autoimmune diseases (23.0% with systemic lupus erythematosus, 15.7% antineutrophil cytoplasmic antibody-associated granulomatous vasculitides, 15.1% multiple sclerosis and 10.0% pemphigus) from 42 centres received a mean dose of 2,440 mg of rituximab over a median (range) of 194 (180 to 1,407) days. The overall rate of serious infections was 5.3 per 100 patient-years during rituximab therapy. Opportunistic infections were infrequent across the whole study population, and mostly occurred in patients with systemic lupus erythematosus. There were 11 deaths (3.0% of patients) after rituximab treatment (mean 11.6 months after first infusion, range 0.8 to 31.3 months), with most of the deaths caused by infections. Overall (n = 293), 13.3% of patients showed no response, 45.1% showed a partial response and 41.6% showed a complete response. Responses were also reflected by reduced use of glucocorticoids and various immunosuppressives during rituximab therapy and follow-up compared with before rituximab. Rituximab generally had a positive effect on patient well-being (physician's visual analogue scale; mean improvement from baseline of 12.1 mm).
Conclusions: Data from this registry indicate that rituximab is a commonly employed, well-tolerated therapy with potential beneficial effects in standard of care-refractory autoimmune diseases, and support the results from other open-label, uncontrolled studies.
We present a measurement of e+e− pair production in central PbAu collisions at 158A GeV/c. As reported earlier, a significant excess of the e+e− pair yield over the expectation from hadron decays is observed. The improved mass resolution of the present data set, recorded with the upgraded CERES experiment at the CERN-SPS, allows for a comparison of the data with different theoretical approaches. The data clearly favor a substantial in-medium broadening of the ρ spectral function over a density-dependent shift of the ρ pole mass. The in-medium broadening model implies that baryon induced interactions are the key mechanism to the observed modifications of the ρ meson at SPS energy.
Artenreiche montane Rasengesellschaften auf Lawinenbahnen des Nationalparks Gesäuse (Österreich)
(2009)
Das Ziel dieser Untersuchung war es, Erkenntnisse über die Bedeutung von Lawinenbahnen für die Biodiversität zu gewinnen. Dazu wurden im Nationalpark Gesäuse (Steiermark, Österreich) 16 Pflanzenbestände in drei ausgewählten Lawinenbahnen pflanzensoziologisch untersucht, vegetationsökologisch charakterisiert sowie mit Vegetationstabelle, bodenkundlichen Analysedaten und topographischen Parametern dokumentiert. Außerdem erfolgte eine Bestandsaufnahme der Schmetterlinge. Die Pflanzenartenvielfalt wurde mit verschiedenen Diversitäts-Indizes beurteilt. Die Ursachen für den Artenreichtum in den untersuchten Lawinenbahnen werden diskutiert.
Die Pflanzenbestände wurden überwiegend zum Origano-Calamagrostietum variae gestellt; eine Einzelaufnahme wurde dem Seslerio-Caricetum sem pervirentis zugeordnet. Im Ersteren dominieren Arten mit hemikryptophytischer Lebensform; Therophyten erreichen die zweithöchste Deckung. Die Pflanzengesellschaft wird von CSR-, CS- und C-Strategen aufgebaut; alle anderen Lebensstrategietypen haben keine Bedeutung. Das Origano-Calamagrostietum variae ist eine artenreiche, natürliche Dauergesellschaft, in der mäßiger Stress und schwache Störungen die Artenzusammensetzung maßgeblich bestimmen. Aktive Lawinenbahnen auf sehr flachgründigen, steinigen, nährstoffarmen, basenreichen Rendzinen in lokalklimatisch wärmebegünstigten steilen Hanglagen der montanen Höhenstufe zählen zu den arten-, blüten- und aspektreichsten und somit ökologisch wertvollsten Vegetationsformationen im Nationalparkgebiet. In den kräuterreichen Pflanzenbeständen wurden im Durchschnitt 71 Gefäßpflanzenarten und 5 Moosarten pro 20 m2 Aufnahmefläche gefunden. Mit dieser hohen Phytodiversität und dem Blütenreichtum ist auch eine große Artenvielfalt bei den Schmetterlingen verbunden. Die untersuchten Lawinenbahnen weisen nicht nur ein hohes Maß an Naturnähe auf, sie dürften auch der ursprüngliche Lebensraum einiger Pflanzenarten des Wirtschafts- und Extensivgrünlandes der Tallagen sein. Auf Grund ihrer hohen naturschutzfachlichen Bedeutung müssen Lawinenbahnen als Ganzes geschützt werden. Periodische oder episodische Lawinenabgänge sind Voraussetzung für die Existenz dieser störungsgeprägten Ökosysteme. Unterhalb von Lawinenbahnen dürfen keine Gebäude oder Infrastrukturen errichtet werden, weil diese Bautätigkeit Schutzobjekte erzeugt. Dadurch würde ein Bedarf für Schutzmaßnahmen entstehen, vor allem in Form von Lawinenverbauungen und Aufforstungen, wodurch Lawinenabgänge verhindert werden.
Protein turnover and quality control by the proteasome is of paramount importance for cell homeostasis. Dysfunction of the proteasome is associated with aging processes and human diseases such as neurodegeneration, cardiomyopathy, and cancer. The regulation, i.e. activation and inhibition of this fundamentally important protein degradation system, is still widely unexplored. We demonstrate here that the evolutionarily highly conserved type II triple-A ATPase VCP and the proteasome inhibitor PSMF1/PI31 interact directly, and antagonistically regulate proteasomal activity. Our data provide novel insights into the regulation of proteasomal activity.
We measured the Coulomb dissociation of 16O into 4He and 12C at the R3B setup in a first campaign within FAIR Phase 0 at GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt. The goal was to improve the accuracy of the experimental data for the 12C(α,γ)16O fusion reaction and to reach lower center-ofmass energies than measured so far.
The experiment required beam intensities of 109 16O ions per second at an energy of 500 MeV/nucleon. The rare case of Coulomb breakup into 12C and 4He posed another challenge: The magnetic rigidities of the particles are so close because of the same mass-to-charge-number ratio A/Z = 2 for 16O, 12C and 4He. Hence, radical changes of the R3B setup were necessary. All detectors had slits to allow the passage of the unreacted 16O ions, while 4He and 12C would hit the detectors' active areas depending on the scattering angle and their relative energies. We developed and built detectors based on organic scintillators to track and identify the reaction products with sufficient precision.
Dilepton spectra for p+p and p+d reactions at 4.9GeV are calculated. We consider electromagnetic bremsstrahlung also in inelastic reactions. N* and Delta* decay present the major contributions to the pho and omega meson yields.Pion annihilation yields only 1.5% of all pho's in p+d. The pho mass spectrum is strongly distorted due to phase space effects, populating dominantly dilepton masses below 770MeV.
Background: Computed tomography (CT) allows estimation of coronary artery calcium (CAC) progression. We evaluated several progression algorithms in our unselected, population-based cohort for risk prediction of coronary and cardiovascular events.
Methods: In 3281 participants (45–74 years of age), free from cardiovascular disease until the second visit, risk factors, and CTs at baseline (b) and after a mean of 5.1 years (5y) were measured. Hard coronary and cardiovascular events, and total cardiovascular events including revascularization, as well, were recorded during a follow-up time of 7.8±2.2 years after the second CT. The added predictive value of 10 CAC progression algorithms on top of risk factors including baseline CAC was evaluated by using survival analysis, C-statistics, net reclassification improvement, and integrated discrimination index. A subgroup analysis of risk in CAC categories was performed.
Results: We observed 85 (2.6%) hard coronary, 161 (4.9%) hard cardiovascular, and 241 (7.3%) total cardiovascular events. Absolute CAC progression was higher with versus without subsequent coronary events (median, 115 [Q1–Q3, 23–360] versus 8 [0–83], P<0.0001; similar for hard/total cardiovascular events). Some progression algorithms added to the predictive value of baseline CT and risk assessment in terms of C-statistic or integrated discrimination index, especially for total cardiovascular events. However, CAC progression did not improve models including CAC5y and 5-year risk factors. An excellent prognosis was found for 921 participants with double-zero CACb=CAC5y=0 (10-year coronary and hard/total cardiovascular risk: 1.4%, 2.0%, and 2.8%), which was for participants with incident CAC 1.8%, 3.8%, and 6.6%, respectively. When CACb progressed from 1 to 399 to CAC5y≥400, coronary and total cardiovascular risk were nearly 2-fold in comparison with subjects who remained below CAC5y=400. Participants with CACb≥400 had high rates of hard coronary and hard/total cardiovascular events (10-year risk: 12.0%, 13.5%, and 30.9%, respectively).
Conclusions: CAC progression is associated with coronary and cardiovascular event rates, but adds only weakly to risk prediction. What counts is the most recent CAC value and risk factor assessment. Therefore, a repeat scan >5 years after the first scan may be of additional value, except when a double-zero CT scan is present or when the subjects are already at high risk.